- Motley Fool•3 hours ago
Fourth-quarter financials suggest Pfizer's Remicade biosimilar may already be denting Johnson & Johnson's market share.
- TheStreet.com•3 hours ago
Here are the winning banks.
- Financial Times•9 hours ago
Johnson & Johnson, the world's largest healthcare company, blamed a stronger dollar as it forecast that 2017 profits and sales would fall below Wall Street expectations, sending the group's shares down ...
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.90 - 31.46|
|52 Week Range||28.25 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.28|
|Dividend & Yield||1.28 (4.03%)|
|1y Target Est||N/A|